Paul D. Burgess, See Remarks at Cerevel Therapeutics Holdings, Inc. (CERE), bought 43,760 shares at $22.93 ($1.0M) on 2023-08-04, disclosed to the SEC on 2023-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.93 | 21,880 | $502K | 50.0% |
| 2 | $22.93 | 21,880 | $502K | 50.0% |
| Total | $22.93 avg | 43,760 | $1.0M | 100% |